The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeting more than tumors: The impact of enfortumab vedotin and pembrolizumab (EV/P) on skeletal muscle loss and sarcopenia in metastatic urothelial carcinoma (mUC).
 
Can Aydogdu
Honoraria - Astellas Pharma; Ipsen
Travel, Accommodations, Expenses - Eisai; Ipsen; Janssen
 
Simon Hahn
No Relationships to Disclose
 
Isabel Brinkmann
No Relationships to Disclose
 
Melanie Götz
No Relationships to Disclose
 
Benazir Enzinger
No Relationships to Disclose
 
Marie Semmler
No Relationships to Disclose
 
Elena Berg
No Relationships to Disclose
 
Frederik Kolligs
No Relationships to Disclose
 
Alexander Tamalunas
No Relationships to Disclose
 
Christian Stief
No Relationships to Disclose
 
Jozefina Casuscelli
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst)
Expert Testimony - Astellas Pharma; Janssen Cilag; MSD Oncology
Travel, Accommodations, Expenses - Bayer; Janssen Oncology; Merck KGaA; Pfizer